Plasma proteins for risk prediction in idiopathic pulmonary fibrosis.
作者信息
Richards Thomas J, Kaminski Naftali, Gibson Kevin F
出版信息
Am J Respir Crit Care Med. 2012 Jun 15;185(12):1329-30. doi: 10.1164/ajrccm.185.12.1329.
Abstract
摘要
相似文献
1
Plasma proteins for risk prediction in idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med. 2012 Jun 15;185(12):1329-30. doi: 10.1164/ajrccm.185.12.1329.
2
Risk prediction in idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med. 2012 Jan 1;185(1):6-7. doi: 10.1164/rccm.201111-1960ED.
3
Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med. 2012 Jan 1;185(1):67-76. doi: 10.1164/rccm.201101-0058OC.
4
Biomarkers in idiopathic pulmonary fibrosis: picking the winners for trials.
Lancet Respir Med. 2015 Jun;3(6):421-2. doi: 10.1016/S2213-2600(15)00084-3. Epub 2015 Mar 12.
5
Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
Sarcoidosis Vasc Diffuse Lung Dis. 2016 Oct 7;33(3):224-234.
6
Significance of molecular biomarkers in idiopathic pulmonary fibrosis: A mini review.
Respir Investig. 2018 Sep;56(5):384-391. doi: 10.1016/j.resinv.2018.06.001. Epub 2018 Jul 17.
7
High levels of IL-6 and IL-8 characterize early-on idiopathic pulmonary fibrosis acute exacerbations.
Cytokine. 2018 Feb;102:168-172. doi: 10.1016/j.cyto.2017.08.019. Epub 2017 Aug 25.
8
Matrix metalloproteinases and endothelial dysfunction: The search for new prognostic markers and for new therapeutic targets for vascular wall imbalance.
Thromb Res. 2015 Jul;136(1):5-6. doi: 10.1016/j.thromres.2015.04.022. Epub 2015 Apr 24.
9
Blood Biomarkers in Idiopathic Pulmonary Fibrosis.
Lung. 2017 Jun;195(3):273-280. doi: 10.1007/s00408-017-9993-5. Epub 2017 Mar 28.
10
Serum prealbumin as prognostic indicator in idiopathic pulmonary fibrosis. A glimmer of hope.
Clin Respir J. 2019 Oct;13(10):659-660. doi: 10.1111/crj.13072. Epub 2019 Aug 23.
引用本文的文献
1
Cutaneous T-cell-attracting chemokine as a novel biomarker for predicting prognosis of idiopathic pulmonary fibrosis: a prospective observational study.
Respir Res. 2021 Jun 17;22(1):181. doi: 10.1186/s12931-021-01779-9.
2
Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells.
Am J Respir Crit Care Med. 2021 Jul 15;204(2):197-208. doi: 10.1164/rccm.202008-3093OC.
3
BAL Cell Gene Expression Is Indicative of Outcome and Airway Basal Cell Involvement in Idiopathic Pulmonary Fibrosis.
Am J Respir Crit Care Med. 2019 Mar 1;199(5):622-630. doi: 10.1164/rccm.201712-2551OC.
本文引用的文献
1
Risk prediction in idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med. 2012 Jan 1;185(1):6-7. doi: 10.1164/rccm.201111-1960ED.
2
Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med. 2012 Jan 1;185(1):67-76. doi: 10.1164/rccm.201101-0058OC.
3
Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med. 2011 Aug 15;184(4):459-66. doi: 10.1164/rccm.201011-1790OC.
4
Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis.
Am J Physiol Lung Cell Mol Physiol. 2010 Jul;299(1):L3-7. doi: 10.1152/ajplung.90637.2008. Epub 2010 Apr 23.
5
Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis.
Chest. 2009 Jun;135(6):1557-1563. doi: 10.1378/chest.08-2209. Epub 2009 Mar 2.
Zotero 插件